Skip to main content
Clinical Trials/NCT03872284
NCT03872284
Completed
Not Applicable

Study of Neuro-ophthalmology Disorders in Autoimmune Encephalitis (NODE)

Hospices Civils de Lyon1 site in 1 country2 target enrollmentJanuary 22, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Autoimmune Encephalitis
Sponsor
Hospices Civils de Lyon
Enrollment
2
Locations
1
Primary Endpoint
Percentage of patients presenting a neuro-ophthalmological abnormality.
Status
Completed
Last Updated
last year

Overview

Brief Summary

Autoimmune encephalitis represents a group of rare and heterogeneous neurological disorders. Pathophysiological mechanisms in these diseases are still unknown. Recently, oculomotor and neurovisual disorders have been described. Cerebral areas and neuronal networks associated with these abnormalities are well described. The investigator proposes to study and describe such neuro-ophthalmological disorders in a prospective cohort of patients with a autoimmune encephalitis, to better understand the pathophysiological basis of this neurological condition.

Registry
clinicaltrials.gov
Start Date
January 22, 2020
End Date
February 26, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of autoimmune encephalitis
  • With or without pathological antibody
  • Aged from 18 to 70 years old
  • Able to understand the aims and methods of this project
  • Non opposed to the participation of this study

Exclusion Criteria

  • Other neurological, psychiatric or systemic conditions, which could induce neuro-ophthalmological signs Cognitive impairment, which is not linked to autoimmune encephalitis
  • Ophthalmological condition, which could modify the interpretation of neuro-ophthalmological data Inability to remain seated
  • Pregnancy or breast feeding
  • Adults under guardianship

Outcomes

Primary Outcomes

Percentage of patients presenting a neuro-ophthalmological abnormality.

Time Frame: Day 0

A neuro-ophthalmological disorder is defined as an abnormality in the oculo-motor movement recording or/and the presence of a neurovisual impairment.

Percentage of patients presenting neuro-ophthalmological abnormality.

Time Frame: At 6 months if an abnormality is found

A neuro-ophthalmological disorder is defined as an abnormality in the oculo-motor movement recording or/and the presence of a neurovisual impairment.

Study Sites (1)

Loading locations...

Similar Trials